Assraa H Jassim-Jaboori and Moses O Oyewumi
The recent FDA approval of the first ever three-dimensional (3D) printed-medicine underscores the potentials of 3D printing (3DP) technology in pharmaceutical drug delivery. This report evaluates the prospects of 3DP technology especially in the area of personalized medicines and offers our perspectives on potential challenges that may hamper a broad-based application in pharmaceutical drug delivery.